CSIMarket
 


Biodesix Inc   (BDSX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Cumulative Biodesix Inc 's Total Debt to Equity for Trailing Twelve Months Period

BDSX's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

BDSX Total Debt to Equity for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth - - -41.52 % 4.46 % -
Y / Y Total Debt Growth 30.11 % 21.31 % 148.7 % 150.23 % -35.94 %
Total Debt to Equity for Trailing Twelve Months Period 5.98 6.17 3 2.25 1.85
Total Ranking # 353 # 142 # 149 # 1247 # 194
Seq. Equity Growth - - -77.92 % - -
Seq. Total Debt Growth 1.18 % -1.69 % 0.32 % 30.39 % -5.66 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis In the III. Quarter company had stockholder deficit.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Laboratories industry 3 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Biodesix Inc . While Total Debt to Equity for Trailing Twelve Months Period total ranking has deteriorated compared to previous quarter from 142 to 353.

What is Debt to Equity Ratio?
BDSX Charts and Quotes
Total Debt to Equity BDSX in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 4
Sector # 84
S&P 500 # 353


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
6.17 2.66 1.04
(Jun 30 2023)   (Sep 30 2021)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Medical Laboratories Industry Total Debt to Equity for Trailing Twelve Months Period
Biodesix Inc   10.14 
Guardant Health Inc   6.09 
Centogene N v   5.43 
Renalytix Plc  4.08 
Iqvia Holdings Inc   2.32 
Foxo Technologies Inc   2.13 
Ge Healthcare Technologies Inc   1.44 
Opgen inc   1.38 
Radnet Inc   1.33 
Inotiv Inc   1.24 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com